agk Antibody

What is AGK and what cellular functions does it perform?

AGK (Acylglycerol kinase) is a protein encoded by the AGK gene in humans. This gene may also be known by several alternative names including CATC5, CTRCT38, MTDPS10, MULK, and hAGK . The protein functions primarily as a multi-substrate lipid kinase involved in lipid metabolism pathways. AGK is predominantly localized to the mitochondria, suggesting its importance in mitochondrial function and bioenergetics. Current research indicates that AGK plays roles in:

• Phosphorylation of acylglycerols

• Mitochondrial lipid metabolism

• Cellular signaling pathways

• Energy metabolism regulation

The protein's high expression in metabolically active tissues such as muscle, heart, kidney, and brain further indicates its importance in tissues with high energy demands .

How do monoclonal and polyclonal AGK antibodies differ in experimental applications?

The choice between monoclonal and polyclonal AGK antibodies significantly impacts experimental outcomes and should be based on specific research requirements.

Monoclonal antibodies:

• Target a single epitope (e.g., ZooMAb clone 1F21 targets a specific epitope within 15 amino acids of the C-terminal region)

• Provide high specificity and consistency between experimental batches

• Demonstrate reduced background and cross-reactivity in sensitive applications

• Offer superior reproducibility for longitudinal studies

• Typically have higher affinity (ZooMAb demonstrates KD of 6.7 x 10-9 in affinity binding assays)

Polyclonal antibodies:

• Recognize multiple epitopes across the AGK protein

• Often provide stronger signals due to binding at multiple sites

• May offer greater detection sensitivity in certain applications

• Can be more tolerant of minor protein denaturation or modifications

• Typically cost less to produce than monoclonals

For applications requiring absolute specificity and reproducibility (such as quantitative analyses), monoclonal antibodies are generally preferred. For detection of low-abundance targets or when protein conformation may be variable, polyclonal antibodies often provide advantages.

What are the validated applications for AGK antibodies in research?

Based on current validation data, AGK antibodies have been successfully employed across multiple research applications:

Western blotting represents the most extensively validated application, with multiple antibodies confirming detection of the expected 47 kDa band across several cell lines . Immunohistochemistry applications have been validated primarily in heart tissue, reflecting AGK's high expression in this organ. For optimal results, researchers should perform preliminary titration experiments to determine ideal antibody concentrations for their specific experimental systems.

What are the optimal sample preparation methods for AGK detection?

Successful AGK antibody applications depend significantly on appropriate sample preparation techniques:

For Western blot analysis:

• Use RIPA or NP-40 based lysis buffers supplemented with protease inhibitors

• Include phosphatase inhibitors if phosphorylation status is relevant

• Heat samples at 95°C for 5 minutes in reducing buffer before loading

• Load 20-50 μg of total protein per lane

• Run samples on 10-12% SDS-PAGE gels to optimize separation around 47 kDa

• Transfer using standard PVDF membranes (nitrocellulose also acceptable)

• Block with 5% non-fat milk or BSA in TBST for at least 1 hour

For immunohistochemistry:

• Fix tissues in 10% neutral buffered formalin

• Perform antigen retrieval (heat-induced epitope retrieval in citrate buffer pH 6.0 is frequently effective)

• Block endogenous peroxidase activity and non-specific binding sites

• Incubate with primary antibody (typically 1:1,000 dilution) overnight at 4°C

• Use appropriate detection systems based on host species of primary antibody

The quality of sample preparation directly impacts antibody performance, with inadequate lysis, improper fixation, or insufficient blocking often leading to false negative results or high background .

How can AGK antibodies be used to investigate mitochondrial dysfunction in disease models?

AGK's localization to mitochondria makes it valuable for studying mitochondrial pathologies through several methodological approaches:

Co-localization studies:

• Use dual immunofluorescence with AGK antibodies and established mitochondrial markers (e.g., TOMM20, COX IV)

• Quantify co-localization coefficients in normal versus diseased states

• Employ super-resolution microscopy to assess changes in mitochondrial morphology and AGK distribution

Expression analysis in disease models:

• Quantify AGK protein levels in tissues from patients or disease models via Western blot

• Correlate expression changes with biomarkers of mitochondrial function (ATP production, membrane potential, ROS generation)

• Analyze AGK expression across disease progression timepoints

Functional assessment:

• Use AGK immunoprecipitation followed by activity assays to assess functional changes

• Combine with blue native PAGE to investigate incorporation into mitochondrial complexes

• Analyze AGK post-translational modifications that may be altered in pathological states

The high expression of AGK in heart and muscle tissues makes these particularly relevant for studying mitochondrial diseases, many of which primarily affect these high-energy tissues . Researchers should include appropriate controls, including tissue from confirmed mitochondrial disease cases and age-matched controls.

What are the best protocols for co-immunoprecipitation studies using AGK antibodies?

Co-immunoprecipitation (Co-IP) can identify AGK interaction partners and reveal novel aspects of its biological function:

Validated antibodies for IP applications:

• Cell Signaling AGK (E1C6X) Rabbit mAb has been specifically validated for IP applications

• ZooMAb clone 1F21 demonstrates high affinity (KD of 6.7 x 10-9), suggesting potential utility in IP protocols

Optimized Co-IP protocol:

• Prepare cell lysates in mild lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, with protease/phosphatase inhibitors)

• Pre-clear lysate with Protein A/G beads for 1 hour at 4°C

• Incubate 500 μg of protein with 2-5 μg of AGK antibody overnight at 4°C

• Add fresh Protein A/G beads and incubate for 2-4 hours at 4°C

• Wash extensively (at least 4-5 times) with lysis buffer

• Elute complexes with sample buffer and analyze by Western blot

Critical controls:

• Input sample (5-10% of lysate used for IP)

• IgG control (matched isotype to primary antibody)

• Reverse IP (using antibodies against suspected interaction partners)

• Validation with recombinant proteins when possible

For detecting novel interaction partners, eluted complexes can be analyzed by mass spectrometry, with results validated using reciprocal co-IP experiments and functional assays .

How should researchers troubleshoot non-specific binding when using AGK antibodies in immunohistochemistry?

Non-specific binding remains a common challenge in AGK immunohistochemistry applications, but can be addressed through systematic optimization:

Common sources of non-specific binding:

• Insufficient blocking of endogenous peroxidase activity

• Inadequate blocking of non-specific binding sites

• Excessively high primary antibody concentration

• Inappropriate antigen retrieval method

• Endogenous biotin (if using avidin-biotin detection systems)

• Cross-reactivity with similar epitopes

Optimization strategies:

• Titrate antibody concentration (starting from 1:1,000 and adjusting as needed)

• Test multiple blocking agents (5% normal serum, 3% BSA, commercial blocking solutions)

• Extend blocking time to 2 hours or more at room temperature

• Compare different antigen retrieval methods:

  • Heat-induced epitope retrieval (citrate buffer pH 6.0, EDTA buffer pH 9.0)

  • Enzymatic retrieval (proteinase K, trypsin)

• Increase wash duration and frequency between steps

• Try alternative detection systems (polymer-based versus avidin-biotin)

Essential controls:

• Omission of primary antibody

• Isotype control antibody at matching concentration

• Known positive tissue (heart tissue has been validated for AGK detection)

• Pre-absorption control (if immunizing peptide is available)

When persistent non-specific binding occurs, switching to a different AGK antibody clone targeting an alternative epitope often resolves the issue, as different epitopes may be more accessible in certain fixation conditions .

What are the considerations for using AGK antibodies in cross-species studies?

Cross-species reactivity is a critical consideration when designing comparative studies:

Validated species reactivity from commercial sources:

• Human: Most extensively validated across multiple antibody clones

• Mouse: Validated for many antibodies, usually with Western blot confirmation

• Rat: Less commonly validated, but several antibodies show reactivity

• Other species: Predictive scores available for bovine, dog, chicken, and other species

Validation approaches for cross-species applications:

• Begin with in silico analysis of epitope conservation across target species

• Test antibody on positive control samples from each species of interest

• Include appropriate negative controls (siRNA knockdown samples)

• Confirm specific band at expected molecular weight (accounting for species-specific variations)

• Validate with orthogonal methods (RT-qPCR, mass spectrometry)

When high confidence cross-reactivity predictions (scores >80) are available, these typically indicate good probability of successful detection, though experimental validation remains essential .

What methodologies are available for studying AGK's role in lipid metabolism pathways?

As a multi-substrate lipid kinase, AGK plays important roles in lipid metabolism that can be investigated through multiple complementary approaches:

Enzymatic activity assays:

• Immunoprecipitate AGK using validated antibodies

• Assess kinase activity using purified lipid substrates

• Measure phosphorylated product formation through radiometric or fluorometric methods

Subcellular localization studies:

• Use fractionation followed by Western blot to track AGK distribution

• Perform co-localization studies with markers of lipid metabolism organelles (mitochondria, lipid droplets, ER)

• Examine redistribution following lipid challenge or metabolic stress

Metabolic flux analysis:

• Combine AGK modulation (overexpression, knockdown) with labeled substrate tracking

• Correlate AGK levels with changes in specific lipid species using lipidomics

• Monitor metabolic adaptation to altered AGK expression

Disease model applications:

• Analyze AGK expression in models of metabolic dysfunction (diabetes, obesity)

• Correlate expression changes with alterations in specific lipid pathways

• Investigate AGK as a potential therapeutic target in lipid metabolism disorders

These approaches can be integrated to develop comprehensive understanding of AGK's functional roles across different metabolic contexts and tissue environments .

How can researchers verify AGK antibody specificity in their experimental systems?

Antibody validation is essential for ensuring reliable and reproducible results:

Recommended validation approaches:

• Genetic validation:

  • Compare detection in wild-type versus AGK knockdown/knockout samples

  • Use siRNA treatment followed by Western blot to confirm specific band disappearance

  • Employ CRISPR-Cas9 engineered cell lines as definitive controls

• Orthogonal validation:

  • Correlate protein detection with mRNA expression (RT-qPCR)

  • Use multiple antibodies targeting different epitopes

  • Compare results across different detection techniques

• Technical validation:

  • Confirm detection at expected molecular weight (47 kDa)

  • Verify tissue distribution matches known expression patterns

  • Test dilution series to establish detection limits and linear range

• Advanced validation:

  • Mass spectrometry confirmation of immunoprecipitated protein

  • Recombinant protein controls with defined concentration

  • Pre-absorption with immunizing peptide/protein

For Western blot applications, U2OS, HeLa, and K562 cell lines serve as reliable positive controls based on validation data from multiple antibody suppliers .

What are the optimal storage and handling conditions for AGK antibodies?

Proper antibody handling directly impacts experimental reproducibility and antibody lifespan:

Storage recommendations:

• Store antibody aliquots at -20°C for long-term stability (avoid repeated freeze-thaw cycles)

• For working solutions, store at 4°C with preservative (0.02% sodium azide)

• Prepare small aliquots (10-20 μL) to minimize freeze-thaw damage

• Some formulations may allow storage at 4°C for up to one month

Handling guidelines:

• Centrifuge vial briefly before opening to collect solution at bottom

• Avoid contamination by using sterile pipette tips

• Do not vortex antibody solutions (gentle mixing only)

• Allow solutions to equilibrate to room temperature before opening

• Return to recommended storage conditions immediately after use

Dilution and reconstitution:

• Use high-quality, low-protein-binding tubes for dilutions

• Prepare working solutions in buffer matching final application

• For Western blot, 5% BSA in TBST often provides better stability than milk-based diluents

• Record all dilution information with lot numbers for reproducibility

Many commercial antibodies come with specific handling recommendations that should be followed to maintain optimal activity throughout the product's shelf life .

How do AGK expression patterns change in different pathological conditions?

Understanding AGK expression changes in disease contexts provides insights into both pathological mechanisms and potential diagnostic applications:

Methodological approaches for expression analysis:

• Quantitative Western blot:

  • Compare AGK levels in paired normal/diseased samples

  • Normalize to appropriate loading controls (β-actin, GAPDH)

  • Use digital image analysis for precise quantification

• Immunohistochemical assessment:

  • Score AGK staining intensity and distribution in tissue sections

  • Compare cellular/subcellular localization between normal and pathological samples

  • Employ digital pathology tools for objective quantification

• Transcriptomic correlation:

  • Analyze AGK mRNA levels in disease datasets

  • Correlate protein expression changes with transcriptional alterations

  • Identify potential regulatory mechanisms affecting AGK expression

While specific disease associations require further investigation, AGK's role in mitochondrial function and lipid metabolism suggests potential involvement in metabolic disorders, cardiovascular diseases, and neurological conditions where these pathways are dysregulated .

What are the validated methods for quantifying AGK expression levels in different cell types?

Accurate quantification of AGK expression is essential for comparative and functional studies:

Western blot quantification:

• Use gradient gels (4-12%) for optimal resolution around 47 kDa

• Include recombinant AGK protein standards for absolute quantification

• Apply digital densitometry with appropriate normalization controls

• Ensure samples fall within linear detection range

Immunofluorescence quantification:

• Maintain consistent image acquisition parameters

• Measure mean fluorescence intensity in defined cellular regions

• Apply background correction using adjacent negative regions

• Analyze sufficient cell numbers for statistical significance (typically >50 cells)

Flow cytometry approach:

• Fix cells with 4% paraformaldehyde

• Permeabilize with 0.1% Triton X-100 or saponin

• Block with 5% serum matching secondary antibody host

• Incubate with AGK antibody (concentration determined by titration)

• Detect with fluorophore-conjugated secondary antibody

• Analyze using appropriate negative controls and gating strategy

For all quantification methods, it's essential to include appropriate controls and perform statistical analysis to determine the significance of observed differences .

What emerging technologies are enhancing AGK antibody applications in research?

Recent technological advances are expanding the utility of AGK antibodies in research:

Single-cell protein analysis:

• Mass cytometry (CyTOF) incorporates metal-tagged AGK antibodies for high-parameter analysis

• Imaging mass cytometry provides spatial context to single-cell protein expression

• Microfluidic-based single-cell Western blotting allows protein quantification from individual cells

Advanced imaging techniques:

• Super-resolution microscopy overcomes diffraction limit for precise localization

• Expansion microscopy physically enlarges samples for improved resolution

• Live-cell imaging with genetically encoded tags complements antibody-based detection

Combinatorial approaches:

• Multiplexed immunofluorescence allows simultaneous detection of AGK with multiple markers

• Correlative light and electron microscopy provides ultrastructural context

• Spatial transcriptomics coupled with protein detection links expression to location

These technologies enable researchers to address increasingly complex questions about AGK function and regulation across different cellular contexts and physiological states .

How can AGK antibodies contribute to biomarker development and translational research?

The specificity of well-validated AGK antibodies makes them valuable tools for translational applications:

Biomarker development pathway:

• Initial discovery phase using proteomic screening

• Validation in defined patient cohorts using specific antibodies

• Assay development and standardization for clinical application

• Implementation in diagnostic or prognostic workflows

Potential translational applications:

• Tissue-based diagnostics for mitochondrial disorders

• Monitoring therapeutic response in metabolic interventions

• Risk stratification in diseases affecting high-expression tissues

Technical considerations for clinical translation:

• Rigorous antibody validation meeting FDA/regulatory requirements

• Development of standardized protocols with defined cutoff values

• Establishment of reference ranges across diverse populations

While AGK biomarker applications remain investigational, its involvement in fundamental metabolic pathways suggests potential utility in multiple disease contexts, particularly those affecting tissues with high AGK expression .